Följ
Ismael Galve-Roperh
Ismael Galve-Roperh
CIBERNED, Complutense University, IRYCIS
Verifierad e-postadress på quim.ucm.es
Titel
Citeras av
Citeras av
År
Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation
I Galve-Roperh, C Sánchez, ML Cortés, TG del Pulgar, M Izquierdo, ...
Nature medicine 6 (3), 313-319, 2000
8322000
Inhibition of Glioma Growth in Vivo by Selective Activation of the CB2 Cannabinoid Receptor
C Sánchez, ML de Ceballos, TG del Pulgar, D Rueda, C Corbacho, ...
Cancer research 61 (15), 5784-5789, 2001
5592001
The emerging functions of endocannabinoid signaling during CNS development
T Harkany, M Guzman, I Galve-Roperh, P Berghuis, LA Devi, K Mackie
Trends in pharmacological sciences 28 (2), 83-92, 2007
4592007
A pilot clinical study of Δ9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme
M Guzman, MJ Duarte, C Blazquez, J Ravina, MC Rosa, I Galve-Roperh, ...
British journal of cancer 95 (2), 197-203, 2006
4442006
Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity
J Palazuelos, T Aguado, MR Pazos, B Julien, C Carrasco, E Resel, ...
Brain 132 (11), 3152-3164, 2009
4132009
The endocannabinoid system drives neural progenitor proliferation
T Aguado, K Monory, J Palazuelos, N Stella, B Cravatt, B Lutz, ...
The FASEB journal 19 (12), 1704-1706, 2005
4002005
Δ9‐Tetrahydrocannabinol induces apoptosis in C6 glioma cells
C Sánchez, I Galve-Roperh, C Canova, P Brachet, M Guzmán
FEBS letters 436 (1), 6-10, 1998
3481998
Endocannabinoid signaling controls pyramidal cell specification and long-range axon patterning
J Mulder, T Aguado, E Keimpema, K Barabás, CJ Ballester Rosado, ...
Proceedings of the National Academy of Sciences 105 (25), 8760-8765, 2008
3452008
The endocannabinoid system promotes astroglial differentiation by acting on neural progenitor cells
T Aguado, J Palazuelos, K Monory, N Stella, B Cravatt, B Lutz, ...
Journal of Neuroscience 26 (5), 1551-1561, 2006
3092006
The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system
AC Campos, Z Ortega, J Palazuelos, MV Fogaça, DC Aguiar, ...
International Journal of Neuropsychopharmacology 16 (6), 1407-1419, 2013
3032013
Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation
I Galve-Roperh, V Chiurchiù, J Díaz-Alonso, M Bari, M Guzmán, ...
Progress in lipid research 52 (4), 633-650, 2013
3012013
The endocannabinoid anandamide inhibits neuronal progenitor cell differentiation through attenuation of the Rap1/B-Raf/ERK pathway
D Rueda, B Navarro, A Martı́nez-Serrano, M Guzmán, I Galve-Roperh
Journal of Biological Chemistry 277 (48), 46645-46650, 2002
2922002
Control of the cell survival/death decision by cannabinoids
M Guzmán, C Sánchez, I Galve-Roperh
Journal of molecular medicine 78, 613-625, 2001
2922001
The CB1 cannabinoid receptor is coupled to the activation of c-Jun N-terminal kinase
D Rueda, I Galve-Roperh, A Haro, M Guzmán
Molecular pharmacology 58 (4), 814-820, 2000
2852000
Non‐psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation
J Palazuelos, T Aguado, A Egia, R Mechoulam, M Guzmán, ...
The FASEB Journal 20 (13), 2405-2407, 2006
2772006
Mechanism of extracellular signal-regulated kinase activation by the CB1 cannabinoid receptor
I Galve-Roperh, D Rueda, TG del Pulgar, G Velasco, M Guzmán
Molecular pharmacology 62 (6), 1385-1392, 2002
2672002
Involvement of sphingomyelin hydrolysis and the mitogen-activated protein kinase cascade in the Δ9-tetrahydrocannabinol-induced stimulation of glucose metabolism in primary …
C Sánchez, I Galve-Roperh, D Rueda, M Guzmán
Molecular pharmacology 54 (5), 834-843, 1998
2471998
Molecular cloning and characterization of a lipid phosphohydrolase that degrades sphingosine-1-phosphate and induces cell death
SM Mandala, R Thornton, I Galve-Roperh, S Poulton, C Peterson, ...
Proceedings of the National Academy of Sciences 97 (14), 7859-7864, 2000
2382000
Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington’s disease
C Blazquez, A Chiarlone, O Sagredo, T Aguado, MR Pazos, E Resel, ...
Brain 134 (1), 119-136, 2011
2272011
Cannabinoids and cell fate
M Guzmán, C Sánchez, I Galve-Roperh
Pharmacology & therapeutics 95 (2), 175-184, 2002
2212002
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20